Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For BRK-B
Valuation Weak
28%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -86.58 5.33 39.71
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -15.51 5.12 6.06
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.06 264.69 259.35
Cash 13.00 87.54 77.46
Capex 22.86 -2.03 -2.64
Free Cash Flow -28.81 2.86 4.02
Revenue -3.53 41.62 43.15
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 13.61 0.22 0.19
Operating Margin 22.45 0.15 0.13
ROA -66.20 0.01 0.04
ROE -66.80 0.02 0.07
ROIC 18.88 0.02 0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of BRK-B is permitted for members.
5 Growth
The "Growth Entry" for the Focus of BRK-B is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of BRK-B is permitted for members.